These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 16043283)
1. COMT Val158Met polymorphism in schizophrenia with obsessive-compulsive disorder: a case-control study. Poyurovsky M; Michaelovsky E; Frisch A; Knoll G; Amir I; Finkel B; Buniak F; Hermesh H; Weizman R Neurosci Lett; 2005 Nov; 389(1):21-4. PubMed ID: 16043283 [TBL] [Abstract][Full Text] [Related]
2. The met(158) allele of catechol-O-methyltransferase (COMT) is associated with obsessive-compulsive disorder in men: case-control study and meta-analysis. Pooley EC; Fineberg N; Harrison PJ Mol Psychiatry; 2007 Jun; 12(6):556-61. PubMed ID: 17264842 [TBL] [Abstract][Full Text] [Related]
3. Lack of association of catechol-O-methyltransferase gene polymorphism in obsessive-compulsive disorder. Erdal ME; Tot S; Yazici K; Yazici A; Herken H; Erdem P; Derici E; Camdeviren H Depress Anxiety; 2003; 18(1):41-5. PubMed ID: 12900951 [TBL] [Abstract][Full Text] [Related]
4. Catechol-O-methyltransferase gene and obsessive-compulsive symptoms in patients with recent-onset schizophrenia: preliminary results. Zinkstok J; van Nimwegen L; van Amelsvoort T; de Haan L; Yusuf MA; Baas F; Linszen D Psychiatry Res; 2008 Jan; 157(1-3):1-8. PubMed ID: 17850881 [TBL] [Abstract][Full Text] [Related]
5. The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia. Ohnishi T; Hashimoto R; Mori T; Nemoto K; Moriguchi Y; Iida H; Noguchi H; Nakabayashi T; Hori H; Ohmori M; Tsukue R; Anami K; Hirabayashi N; Harada S; Arima K; Saitoh O; Kunugi H Brain; 2006 Feb; 129(Pt 2):399-410. PubMed ID: 16330500 [TBL] [Abstract][Full Text] [Related]
6. Catechol-O-methyltransferase Val158Met genotype variation is associated with prefrontal-dependent task performance in schizotypal personality disorder patients and comparison groups. Minzenberg MJ; Xu K; Mitropoulou V; Harvey PD; Finch T; Flory JD; New AS; Goldman D; Siever LJ Psychiatr Genet; 2006 Jun; 16(3):117-24. PubMed ID: 16691129 [TBL] [Abstract][Full Text] [Related]
7. Catechol-O-methyltransferase gene Val108/158Met polymorphism, and susceptibility to schizophrenia: association is more significant in women. Sazci A; Ergul E; Kucukali I; Kilic G; Kaya G; Kara I Brain Res Mol Brain Res; 2004 Dec; 132(1):51-6. PubMed ID: 15548428 [TBL] [Abstract][Full Text] [Related]
8. Catechol-O-methyltransferase Val158Met polymorphism in relation to aggressive schizophrenia in a Korean population. Kim YR; Kim JH; Kim SJ; Lee D; Min SK Eur Neuropsychopharmacol; 2008 Nov; 18(11):820-5. PubMed ID: 18789857 [TBL] [Abstract][Full Text] [Related]
9. The catechol O-methyltransferase Val158Met polymorphism and herpes simplex virus type 1 infection are risk factors for cognitive impairment in bipolar disorder: additive gene-environmental effects in a complex human psychiatric disorder. Dickerson FB; Boronow JJ; Stallings C; Origoni AE; Cole S; Leister F; Krivogorsky B; Yolken RH Bipolar Disord; 2006 Apr; 8(2):124-32. PubMed ID: 16542182 [TBL] [Abstract][Full Text] [Related]
11. Association study of COMT gene Val158Met polymorphism with auditory P300 and performance on neurocognitive tests in patients with schizophrenia and their relatives. Golimbet V; Gritsenko I; Alfimova M; Lebedeva I; Lezheiko T; Abramova L; Kaleda V; Ebstein R World J Biol Psychiatry; 2006; 7(4):238-45. PubMed ID: 17071544 [TBL] [Abstract][Full Text] [Related]
13. Catechol-O-methyltransferase val108/158met genotype predicts working memory response to antipsychotic medications. Weickert TW; Goldberg TE; Mishara A; Apud JA; Kolachana BS; Egan MF; Weinberger DR Biol Psychiatry; 2004 Nov; 56(9):677-82. PubMed ID: 15522252 [TBL] [Abstract][Full Text] [Related]
14. Association between the dopamine D2 receptor TaqI A2 allele and low activity COMT allele with obsessive-compulsive disorder in males. Denys D; Van Nieuwerburgh F; Deforce D; Westenberg H Eur Neuropsychopharmacol; 2006 Aug; 16(6):446-50. PubMed ID: 16427255 [TBL] [Abstract][Full Text] [Related]
15. Catechol-O-methyltransferase gene Val158Met polymorphism and obsessive compulsive disorder susceptibility: a meta-analysis. Kumar P; Rai V Metab Brain Dis; 2020 Feb; 35(2):241-251. PubMed ID: 31879835 [TBL] [Abstract][Full Text] [Related]
16. Influence of catechol-O-methyltransferase Val158Met polymorphism on neuropsychological and functional outcomes of classical rehabilitation and cognitive remediation in schizophrenia. Bosia M; Bechi M; Marino E; Anselmetti S; Poletti S; Cocchi F; Smeraldi E; Cavallaro R Neurosci Lett; 2007 May; 417(3):271-4. PubMed ID: 17383818 [TBL] [Abstract][Full Text] [Related]
17. The role of the COMT Val(158)Met polymorphism in the phenotypic expression of obsessive-compulsive disorder. Katerberg H; Cath DC; Denys DA; Heutink P; Polman A; van Nieuwerburgh FC; Deforce DL; Bochdanovits Z; van Balkom AJ; den Boer JA Am J Med Genet B Neuropsychiatr Genet; 2010 Jan; 153B(1):167-76. PubMed ID: 19521967 [TBL] [Abstract][Full Text] [Related]
18. No association found between 158 Val/Met polymorphism of the COMT gene and schizophrenia with minor physical anomalies. Joo EJ; Jeong SH; Ahn YM; Lee KY; Chang Yoon S; Kim EJ; Kim SU; Cho SC; Sik Kim Y Psychiatry Res; 2005 Sep; 136(2-3):83-91. PubMed ID: 16109444 [TBL] [Abstract][Full Text] [Related]